Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Income from Non-Controlling Interests (2023)

Historic Income from Non-Controlling Interests for Ironwood Pharmaceuticals (IRWD) over the last 3 years, with Q4 2023 value amounting to -$658000.0.

  • Ironwood Pharmaceuticals' Income from Non-Controlling Interests changed N/A to -$658000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$29.3 million, marking a year-over-year change of. This contributed to the annual value of -$29.3 million for FY2023, which is N/A changed from last year.
  • As of Q4 2023, Ironwood Pharmaceuticals' Income from Non-Controlling Interests stood at -$658000.0.
  • Ironwood Pharmaceuticals' Income from Non-Controlling Interests' 5-year high stood at -$658000.0 during Q4 2023, with a 5-year trough of -$27.3 million in Q2 2023.